Although it is accepted that consumption of low-digestible carbohydrates (LDCs) can have undesirable gastrointestinal effects in some individuals, few tolerance studies are comparable in terms of symptom definition or the methodology adopted. This workshop considered the main gastrointestinal symptoms that can occur following consumption of LDCs and if current symptom definitions were wholly appropriate. The study protocols that should be adopted to investigate the gastrointestinal (GI) tolerance of LDCs were discussed and what affects tolerance, such as host factors and types of LDC ingested. The workshop debated if the occurrence of GI symptoms following consumption of LDCs outweighed their perceived functional benefits. Because GI symptoms are difficult to measure the workshop agreed that double-blind, controlled cross-over studies should be used to assess the GI responses of individuals following consumption of LDCs. Furthermore, any association between different symptoms and the occurrence of more than one symptom, i.e. multiple symptoms should be considered.
Bowel habit
There is great variability amongst individuals in bowel habit. The normal range is from three bowel movements per week to three per day, with a modal frequency of one per day. Changes in bowel habit may be assessed by a variety of means. Stool collection provides useful data in terms of stool weight and consistency but is difficult to achieve except in controlled diet studies and is not practical in community-based investigations. In community studies, bowel movement frequency, consistency, urgency and other observations such as stool colour and odour may be recorded in diaries by study participants. Such data are useful in determining changes in bowel habit following consumption of LDCs.
Intestinal gas
Colonic fermentation of LDCs may lead to a rapid build up of intestinal gas and the symptoms of abdominal colic, bloating, abdominal noise (borborygmi) and flatulence. The workshop considered that each of these symptoms could be subjectively measured in terms of frequency, severity and duration by use of subject diaries and interview. Measurement of abdominal girth was also identified as a useful index of abdominal bloating. Because gases are absorbed across the colonic mucosa and excreted via the lungs breath hydrogen and methane analyses were seen as useful techniques in the assessment of gastrointestinal fermentation following consumption of LDCs.
Benefits and disadvantages of LDC consumption
The workshop considered the potential health benefits following consumption of different LDCs compared to the potential disadvantages in terms of GI symptoms. The workshop broadly agreed that the benefits of LDC consumption outweighed their disadvantages ( Table 2 ). The workshop agreed that GI symptoms following consumption of LDCs were often transient compared to the lasting benefits derived from their consumption and those individuals that find themselves sensitive to the effects of LDC ingestion can reduce or stop their intake with no further effects. However, LDCs in different product applications have different potential health benefits, for example polyols in sugar-free products are non-cariogenic whereas fructo-oligosaccharides are promoted as more prebiotic in nature.
Factors that affect tolerance
The workshop discussed some of the factors that affect tolerance of LDCs in view of the presentations made by Drs Marteau and Livesey (p.S17±S21 and S7±S16). It is apparent that GI tolerance does not depend solely on the type of LDC or the dose ingested but on many other factors. These are summarised in Table 3 . However, the effect on GI tolerance of LDC consumption pattern, naturally occurring LDCs in the diet and interactions with other dietary components requires further research (Cummings et al.) .
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